About the event:

Celebrating its 12th successful year, SCOPE Summit 2021 takes place March 2-4,2021 as a fully virtual event. During these difficult times of a global pandemic, the work this clinical research community does is more important than ever and requires collaboration and innovation.

Over the course of three stimulating days of in-depth discussions in 23 different conferences, 5 plenary keynote sessions, the 5th annual Participant Engagement Awards, the new China Clinical Development Partnering event and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial innovation, planning, management and operations, including: De-Centralized Trials, Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Telemedicine, Data Strategy and Analytics, Sensors and Wearables, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Resource Management, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Artificial Intelligence, Post-Marketing Studies, Observational Research, Accessing and Generating RWD, Clinical Biomarker Strategy, Clinical Supply Chain, Precision Medicine, Clinical Biomarkers and Biospecimens, and Central Lab Solutions, and expanded coverage on Medical Device Clinical Trial Operations and Regulations and Clinical Supply.

SCOPE attracted more than 2,200 leaders in clinical operations and research in 2020, and we are looking for new speakers and innovative stories for the 2021 program. Each of our conference tracks will feature best practice case studies relevant to clinical innovation and operations experts and those new to the field. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, advocacy organizations and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials. We look forward to you and your team joining us in the first ever virtual SCOPE!




2020 Attendee Profile

SCOPE 2020 ATTRACTS RECORD ATTENDANCE WITH MORE THAN 2,200 PARTICIPANTS, GROWING BY MORE THAN 10% FOR THE FIFTH CONSECUTIVE YEAR

The impressive executive audience at SCOPE came together for invaluable networking opportunities with more than 53% of the attendees titled as a decision-maker from leading Pharma (18%), Biotech companies (19%) and, CRO (36%). Industry leaders and key decision-makers representing 28 different countries and more than 770 unique organizations shared case studies, collaborated on best practices, and provided unique perspectives on poignant issues that the field currently faces.

2020 EVENT FEATURED

2,200+
participants
20
conferences
Participant
Engagement Awards
New SCOPE Scientific Symposium (SSS)
Dedicated Exhibit Hall Hours & Networking Functions
Interactive Breakout Discussions

The impressive executive audience at SCOPE came together for invaluable networking opportunities with more than 53% of the attendees titled as a decision-maker from leading Pharma (18%), Biotech companies (19%) and, CRO (36%). Industry leaders and key decision-makers representing 28 different countries and more than 770 unique organizations shared case studies, collaborated on best practices, and provided unique perspectives on poignant issues that the field currently faces.